134 related articles for article (PubMed ID: 9864088)
1. Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats.
Wolf DC; Crosby LM; George MH; Kilburn SR; Moore TM; Miller RT; DeAngelo AB
Toxicol Pathol; 1998; 26(6):724-9. PubMed ID: 9864088
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen.
Kurokawa Y; Maekawa A; Takahashi M; Hayashi Y
Environ Health Perspect; 1990 Jul; 87():309-35. PubMed ID: 2269236
[TBL] [Abstract][Full Text] [Related]
3. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration.
Kurokawa Y; Aoki S; Matsushima Y; Takamura N; Imazawa T; Hayashi Y
J Natl Cancer Inst; 1986 Oct; 77(4):977-82. PubMed ID: 3463824
[TBL] [Abstract][Full Text] [Related]
4. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity.
Delker D; Hatch G; Allen J; Crissman B; George M; Geter D; Kilburn S; Moore T; Nelson G; Roop B; Slade R; Swank A; Ward W; DeAngelo A
Toxicology; 2006 Apr; 221(2-3):158-65. PubMed ID: 16442688
[TBL] [Abstract][Full Text] [Related]
5. Origin and distribution of potassium bromate-induced testicular and peritoneal mesotheliomas in rats.
Crosby LM; Morgan KT; Gaskill B; Wolf DC; DeAngelo AB
Toxicol Pathol; 2000; 28(2):253-66. PubMed ID: 10805143
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the duration of treatment and the incidence of renal cell tumors in male F344 rats administered potassium bromate.
Kurokawa Y; Matsushima Y; Takamura N; Imazawa T; Hayashi Y
Jpn J Cancer Res; 1987 Apr; 78(4):358-64. PubMed ID: 3108216
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity of potassium bromate administered in the drinking water to male B6C3F1 mice and F344/N rats.
DeAngelo AB; George MH; Kilburn SR; Moore TM; Wolf DC
Toxicol Pathol; 1998; 26(5):587-94. PubMed ID: 9789944
[TBL] [Abstract][Full Text] [Related]
8. Dose-related changes of oxidative stress and cell proliferation in kidneys of male and female F344 rats exposed to potassium bromate.
Umemura T; Kitamura Y; Kanki K; Maruyama S; Okazaki K; Imazawa T; Nishimura T; Hasegawa R; Nishikawa A; Hirose M
Cancer Sci; 2004 May; 95(5):393-8. PubMed ID: 15132765
[TBL] [Abstract][Full Text] [Related]
9. Lack of renal tumour-initiating activity of a single dose of potassium bromate, a genotoxic renal carcinogen in male F344/NCr rats.
Kurata Y; Diwan BA; Ward JM
Food Chem Toxicol; 1992 Mar; 30(3):251-9. PubMed ID: 1618449
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity of potassium bromate administered orally to F344 rats.
Kurokawa Y; Hayashi Y; Maekawa A; Takahashi M; Kokubo T; Odashima S
J Natl Cancer Inst; 1983 Nov; 71(5):965-72. PubMed ID: 6580498
[TBL] [Abstract][Full Text] [Related]
11. Etiology of bromate-induced cancer and possible modes of action-studies in Japan.
Umemura T; Kurokawa Y
Toxicology; 2006 Apr; 221(2-3):154-7. PubMed ID: 16473452
[TBL] [Abstract][Full Text] [Related]
12. Dose-related enhancing effect of potassium bromate on renal tumorigenesis in rats initiated with N-ethyl-N-hydroxyethyl-nitrosamine.
Kurokawa Y; Aoki S; Imazawa T; Hayashi Y; Matsushima Y; Takamura N
Jpn J Cancer Res; 1985 Jul; 76(7):583-9. PubMed ID: 3928554
[TBL] [Abstract][Full Text] [Related]
13. Lack of mutagenic and toxic effects of low dose potassium bromate on kidneys in the Big Blue rat.
Yamaguchi T; Wei M; Hagihara N; Omori M; Wanibuchi H; Fukushima S
Mutat Res; 2008 Mar; 652(1):1-11. PubMed ID: 18243045
[TBL] [Abstract][Full Text] [Related]
14. Kidney toxicogenomics of chronic potassium bromate exposure in f344 male rats.
Geter DR; Ward WO; Knapp GW; Deangelo AB; Rubis JA; Owen RD; Allen JW; Delker DA
Transl Oncogenomics; 2006; 1():33-52. PubMed ID: 23662038
[TBL] [Abstract][Full Text] [Related]
15. A possible role for oxidative stress in potassium bromate (KBrO3) carcinogenesis.
Umemura T; Sai K; Takagi A; Hasegawa R; Kurokawa Y
Carcinogenesis; 1995 Mar; 16(3):593-7. PubMed ID: 7697818
[TBL] [Abstract][Full Text] [Related]
16. Induction of thyroid and liver tumors by chronic exposure to 2-methylimidazole in F344/N rats and B6C3F1 mice.
Chan PC; Sills RC; Kissling GE; Nyska A; Richter W
Arch Toxicol; 2008 Jun; 82(6):399-412. PubMed ID: 17924096
[TBL] [Abstract][Full Text] [Related]
17. Comparison of potential protective effects of melatonin, indole-3-propionic acid, and propylthiouracil against lipid peroxidation caused by potassium bromate in the thyroid gland.
Karbownik M; Stasiak M; Zasada K; Zygmunt A; Lewinski A
J Cell Biochem; 2005 May; 95(1):131-8. PubMed ID: 15723291
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of taurine against potassium bromate-induced hemoglobin oxidation, oxidative stress, and impairment of antioxidant defense system in blood.
Ahmad MK; Mahmood R
Environ Toxicol; 2016 Mar; 31(3):304-13. PubMed ID: 25213677
[TBL] [Abstract][Full Text] [Related]
19. Oxidative DNA damage and cell proliferation in kidneys of male and female rats during 13-weeks exposure to potassium bromate (KBrO3).
Umemura T; Takagi A; Sai K; Hasegawa R; Kurokawa Y
Arch Toxicol; 1998 Apr; 72(5):264-9. PubMed ID: 9630011
[TBL] [Abstract][Full Text] [Related]
20. Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold.
Wei M; Hamoud AS; Yamaguchi T; Kakehashi A; Morimura K; Doi K; Kushida M; Kitano M; Wanibuchi H; Fukushima S
Toxicol Pathol; 2009 Dec; 37(7):983-91. PubMed ID: 19833912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
